Real-world evidence on the additional cancer risk reduction of ezetimibe: a 10-year nationwide retrospective cohort study emulating a target trial

Abstract Background Lipid-lowering therapies, particularly statins, have been associated with a reduced risk of cancer. However, the potential additional protective effects of ezetimibe remain unclear in real-world settings. This study investigated whether statin/ezetimibe combination therapy provid...

Descrición completa

Detalles Bibliográficos

Principais autores:	Yohwan Lim, Eunji Kim, Eunjung Hwang, Koanhoi Kim, Yonghae Son, Sang Yeoup Lee, Young Hye Cho, Eun-Ju Park, Youngin Lee, Sae Rom Lee, Jung-In Choi, Han-Sol Jeong, Su-Jung Park, Soo Min Son, Ryuk Jun Kwon
Formato:	Artigo
Idioma:	Inglês
Publicado:	Springer 2025-09-01
Series:	Journal of Cancer Research and Clinical Oncology
Assuntos:	Cancer Hyperlipidemia Lipid-lowering therapy Statin Ezetimibe Real-world data
Acceso en liña:	https://doi.org/10.1007/s00432-025-06339-y
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!